# PomDoctor

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pomdoctor

- Industry: Healthcare
- Headquarters: Guangzhou, China
- Website: www.7lk.com
- Total disclosed funding: $49M
- Latest round: Series B (Aug 10, 2018)
- Investors on record: 13

## About

Founded in 2010 and based in Guangzhou, China, PomDoctor Limited was established by medical professionals seeking to improve accessibility to healthcare and pharmaceuticals in China. The company evolved from a doctor-led initiative into a multi-segment healthcare enterprise encompassing offline pharmacies, medical e-commerce, distribution, and telemedicine. It operates primarily through Guangzhou Qilekang Digital Health Medical Technology Co., Ltd.. In October 2025, the company was 

The company online medical consultations, prescription renewals and medication delivery services through its digital health platform. Its model integrates AI-driven tools for chronic disease management, connecting physicians and patients across a full-cycle care system that includes diagnosis, treatment, and post-consultation follow-up. The company also offers pharmaceutical distribution and insurance-linked health services, building a closed-loop “online diagnosis + medication + payment” healthcare ecosystem.

The company generates revenue from online consultation fees, pharmaceutical product sales and digital health management subscriptions.

The company plans to extend its digital healthcare model beyond liver disease into cardiovascular, diabetes, rheumatology and pediatric ophthalmology fields. Future initiatives include expanding AI-based clinical support systems, enhancing R&D in digital health, and scaling its supply chain network to strengthen service coverage across China.

## Funding rounds

- Series B, Aug 10, 2018 — GTJA Investment Group, Genertec Investment Managers
- Series B, Dec 29, 2016 — Hong Shan, Greenwoods Asset Management, JD.com, Inc., Share Capital, Orient Securities Capital, THG Ventures, Huajin Lingchuang Fund Management
- Series B, Sep 25, 2016 — Shanghai China Healthcare Venture Management
- Series A, Mar 2, 2015, $49M — Govtor, Lotus Lake Capital, Grand Yangtze Capital

## Investors

- Govtor (https://capitalatlas.ai/funds/govtor) — Series A
- Lotus Lake Capital (https://capitalatlas.ai/funds/lotus-lake-capital) — Series A
- Grand Yangtze Capital (https://capitalatlas.ai/funds/grand-yangtze-capital) — Series A
- Shanghai China Healthcare Venture Management (https://capitalatlas.ai/funds/shanghai-china-healthcare-venture-management) — Series B
- Hong Shan — Series B
- Greenwoods Asset Management (https://capitalatlas.ai/funds/greenwoods-asset-management) — Series B
- JD.com, Inc. — Series B
- Share Capital (https://capitalatlas.ai/funds/share-capital) — Series B
- Orient Securities Capital — Series B
- THG Ventures (https://capitalatlas.ai/funds/thg-ventures) — Series B
- Huajin Lingchuang Fund Management (https://capitalatlas.ai/funds/huajin-lingchuang-fund-management) — Series B
- GTJA Investment Group (https://capitalatlas.ai/funds/gtja-investment-group) — Series B
- Genertec Investment Managers — Series B